MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/jhc.s585217

Медицинская библиотека · Journal of hepatocellular carcinoma · 2026

USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1.

Jiang Hanlin, Huang Lining, Chen Jiahao, Jiang Zongying, Niu Weiqiao, Wu Jianwu, Qiao Zhiming, Pan Yujia, Jiang Xinwei

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. Ubiquitin-specific proteases (USPs) modulate tumor progression by regulating substrate protein stability. However, the mechanisms of most DUBs in HCC remain poorly understood. This study aimed to investigate the role of USP9X in promoting HCC cell proliferation, survival, migration, and invasion.

METHODS

Transcriptomic and clinical data of LIHC patients were obtained from TCGA to assess USP9X expression, prognosis, and pathway enrichment. USP9X expression in HCC and adjacent tissues was examined by immunohistochemistry and Western blotting. Functional assays (CCK-8, colony formation, wound-healing, Transwell) were performed following USP9X knockdown or overexpression in Lm3 and Huh7 cells. The USP9X-HSP90AA1 interaction was evaluated by Co-IP and mass spectrometry, and deubiquitination assays elucidated the mechanism. In vitro and in vivo experiments determined the effects of USP9X-HSP90AA1 signaling on HCC growth and metastasis.

RESULTS

Bioinformatic analyses revealed that USP9X expression was significantly elevated in LIHC tissues and correlated with poor prognosis. Immunohistochemistry and Western blotting confirmed higher USP9X protein levels in tumor tissues. Knockdown of USP9X inhibited proliferation and migration of Lm3 and Huh7 cells, whereas USP9X overexpression enhanced these phenotypes. Co-IP demonstrated a direct interaction between USP9X and HSP90AA1, and deubiquitination assays showed that USP9X decreased HSP90AA1 ubiquitination and increased its stability. Both in vitro and in vivo data indicated that USP9X promotes HCC progression through stabilization of HSP90AA1.

CONCLUSION

USP9X is a tumor-promoting factor that accelerates HCC progression by stabilizing HSP90AA1, highlighting USP9X as a potential therapeutic target for HCC.

Для цитирования: Jiang Hanlin, Huang Lining, Chen Jiahao, Jiang Zongying, Niu Weiqiao, Wu Jianwu, Qiao Zhiming, Pan Yujia, Jiang Xinwei. USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1.. Journal of hepatocellular carcinoma. 2026. DOI: 10.2147/jhc.s585217.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.